Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2015, Article ID 740212, 11 pages
http://dx.doi.org/10.1155/2015/740212
Clinical Study

Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months

1INTERACT Program, Kigali, Rwanda
2College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda
3Academic Medical Center (AMC), Department of Global Health and Amsterdam Institute for Global Health and Development (AIGHD), 1105 BM Amsterdam, Netherlands
4Department of Epidemiology and Biostatistics, VU University Medical Center, 1007 MB Amsterdam, Netherlands
5Treatment and Research for AIDS Center (TRAC-Plus), Kigali, Rwanda
6National Reference Laboratory, Kigali, Rwanda
7Institute of Infection and Global Health, University of Liverpool, Liverpool L69 7BE, UK
8Kigali University Teaching Hospital, Kigali, Rwanda
9Rinda Ubuzima, Kigali, Rwanda
10Biomedical Research, Royal Tropical Institute, 1105 AZ Amsterdam, Netherlands
11Ministry of Health of Rwanda, Rwanda

Received 16 April 2015; Revised 28 June 2015; Accepted 29 June 2015

Academic Editor: David Katzenstein

Copyright © 2015 Brenda Asiimwe-Kateera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, Global Report: UNAIDS Report on the Global AIDS Epidemic 2013, UNAIDS, Geneva, Switzerland, 2013.
  2. S. L. Braunstein, C. M. Ingabire, E. Geubbels et al., “High burden of prevalent and recently acquired HIV among female sex workers and female HIV voluntary testing center clients in Kigali, Rwanda,” PLoS ONE, vol. 6, no. 9, Article ID e24321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. L. Braunstein, C. M. Ingabire, E. Kestelyn et al., “High human immunodeficiency virus incidence in a cohort of rwandan female sex workers,” Sexually Transmitted Diseases, vol. 38, no. 5, pp. 385–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. World Health Organization, Global Update on HIV Treatment 2013: Results, Impact and Opportunitie, World Health Organization, Geneva, Switzerland, 2013.
  5. T. Roberts, H. Bygrave, E. Fajardo, and N. Ford, “Challenges and opportunities for the implementation of virological testing in resource-limited settings,” Journal of the International AIDS Society, vol. 15, no. 2, Article ID 17324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Dragović, D. Salemović, J. Ranin, J. Nikolić, J. Kušić, and D. Jevtović, “Clinical and immunologic outcomes of HAART-treated HIV-infected women in resource constrain settings: the Belgrade study,” Women & Health, vol. 54, no. 1, pp. 35–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Nash, M. Katyal, M. W. G. Brinkhof et al., “Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies,” AIDS, vol. 22, no. 17, pp. 2291–2302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. S. Sow, L. F. Otieno, E. Bissagnene et al., “Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries,” Journal of Acquired Immune Deficiency Syndromes, vol. 44, no. 3, pp. 262–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. National Institute of Statistics of Rwanda (NISR), Ministry of Health of Rwanda (MOH), and ICF International, Rwanda Demographic and Health Survey 2010, NISR, MOH, ICF International, Calverton, Md, USA, 2011.
  10. Ministry of Health of Rwanda, National Guide for the Syndrome Care of Sexually Transmitted Infections in Rwanda, Edition 2002, Ministry of Health, Kigali, Rwanda, 2002.
  11. F. O. Otieno, R. Ndivo, S. Oswago et al., “Evaluation of syndromic management of sexually transmitted infections within the Kisumu Incidence Cohort Study,” International Journal of STD & AIDS, vol. 25, no. 12, pp. 851–859, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. N. J. Veldhuijzen, S. L. Braunstein, J. Vyankandondera et al., “The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda,” BMC Infectious Diseases, vol. 11, article 333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. W. Gitau, S. M. Graham, L. N. Masese et al., “Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy,” AIDS, vol. 24, no. 17, pp. 2733–2737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Denslow, A. F. Rositch, C. Firnhaber, J. Ting, and J. S. Smith, “Incidence and progression of cervical lesions in women with HIV: a systematic global review,” International Journal of STD and AIDS, vol. 25, no. 3, pp. 163–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Kabami, E. Turyakira, S. Biraro, and F. Bajunirwe, “Increasing incidence of pregnancy among women receiving HIV care and treatment at a large urban facility in western Uganda,” Reproductive Health, vol. 11, article 81, 2014. View at Publisher · View at Google Scholar
  16. J. N. Mumah, A. K. Ziraba, and E. M. Sidze, “Effect of HIV status on fertility intention and contraceptive use among women in nine sub-Saharan African countries: evidence from Demographic and Health Surveys,” Global Health Action, vol. 7, Article ID 25579, 2014. View at Google Scholar
  17. E. W. Ngugi, A. A. Kim, R. Nyoka et al., “Contraceptive practices and fertility desires among HIV-infected and uninfected women in Kenya: results from a nationally representative study,” Journal of Acquired Immune Deficiency Syndromes, vol. 66, supplement 1, pp. S75–S81, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Vyankandondera, K. Mitchell, B. Asiimwe-Kateera et al., “Antiretroviral therapy drug adherence in Rwanda: perspectives from patients and healthcare workers using a mixed-methods approach,” AIDS Care, vol. 25, no. 12, pp. 1504–1512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Ministry of Health of Rwanda, National HIV Care and Treatment Guidelines, Ministry of Health of Rwanda, Kigali, Rwanda, 2007.
  20. A. J. C. van den Brule, R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. L. M. Meijer, and P. J. F. Snijders, “GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 779–787, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Rusine, P. Ondoa, B. Asiimwe-Kateera et al., “High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda,” PLoS ONE, vol. 8, no. 5, Article ID e63303, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Ministry of Health of Rwanda, National HIV Treatment and Care Guidelines, Ministry of Health of Rwanda, Kigali, Rwanda, 2009.
  23. World Health Organization, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, World Health Organization, Geneva, Switzerland, 2013.
  24. J. Rusine, B. Asiimwe-Kateera, J. van de Wijgert et al., “Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda,” PLoS ONE, vol. 8, no. 8, Article ID e64345, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Tapsfield, T. Mathews, M. Lungu, and J. J. van Oosterhout, “Underreporting of side effects of standard first-line ART in the routine setting in Blantyre, Malawi,” Malawi Medical Journal, vol. 23, no. 4, pp. 115–117, 2011. View at Google Scholar · View at Scopus
  26. H. N. Luma, M. S. Doualla, S. P. Choukem et al., “Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study,” The Pan African Medical Journal, vol. 12, p. 87, 2012. View at Google Scholar
  27. S. G. Abaissa, D. Fekade, Y. Feleke, T. Seboxa, and E. Diro, “Adverse drug reactions associated with antiretroviral treatment among adult ethiopian patients in a tertiary hospital,” Ethiopian Medical Journal, vol. 50, no. 2, pp. 107–113, 2012. View at Google Scholar · View at Scopus
  28. W.-T. Chen, “Antiretroviral therapy (ART) side effects impacted on quality of life, and depressive symptomatology: a mixed-methods study,” Journal of AIDS & Clinical Research, vol. 4, article 218, 2013. View at Google Scholar · View at Scopus
  29. Ministry of Health of Rwanda, Rwanda HIV and AIDS National Strategic Plan June 2013–June 2018, Ministry of Health, Kigali, Rwanda, 2013.
  30. S. I. McCoy, R. Buzdugan, L. J. Ralph et al., “Unmet need for family planning, contraceptive failure, and unintended pregnancy among HIV-infected and HIV-uninfected women in Zimbabwe,” PLoS ONE, vol. 9, no. 8, Article ID e105320, 2014. View at Publisher · View at Google Scholar
  31. G. Antelman, A. Medley, R. Mbatia et al., “Pregnancy desire and dual method contraceptive use among people living with HIV attending clinical care in Kenya, Namibia and Tanzania,” Journal of Family Planning and Reproductive Health Care, vol. 41, article e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Ministry of Health of Rwanda and UNAIDS, Gender Assessment of Rwanda's National HIV Response, UNAIDS, Geneva, Switzerland, 2013.
  33. National AIDS Control Commission of Rwanda, Aide Memoire: Universal Access to HIV Prevention, Treatment, Care and Support, National AIDS Control Commission, Kigali, Rwanda, 2010.
  34. A. Binagwaho, C. M. Wagner, M. Gatera, C. Karema, C. T. Nutt, and F. Ngabo, “Achieving high coverage in Rwanda's national human papillomavirus vaccination programme,” Bulletin of the World Health Organization, vol. 90, no. 8, pp. 623–628, 2012. View at Publisher · View at Google Scholar · View at Scopus